Inhibition of the growth of sarcoma 180 ascites cells by combinations of inhibitors of nucleic acid biosynthesis and the cupric chelate of kethoxal bis-(thiosemicarbazone).

نویسندگان

  • A C Sartorelli
  • B A Booth
چکیده

The tumor-inhibitory jxitency of combinations of the cupric chelate of kethoxal bis(thiosemicarbazone) [Cu(II)KTS] with several compounds that cause inhibition of the synthesis of DNA by different biochemical mechanisms was assessed in Sarcoma 180 ascites cells. Cu(II)KTS prolonged the survival time of tumor-bearing mice, whereas neither cupric chloride, copper stéarate,nor kethoxal bis(thiosemicarbazone) caused a significant lengthening of the life-span of similar animals. Synergistic inhibition of tumor growth was achieved by combinations of either 6-thioguanine or Ar-isopropyl-a-(2-methylhydrazino)-ptoluamide with Cu(II)KTS. The more potent of these drug combinations was the mixture of 6-thioguanine and Cu(II)KTS. In contrast, combinations of cupric chloride or kethoxal bis(thiosemicarbazone) with either 6-thioguanine or A'-isopropyl-

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Inhibition of the Growth of Sarcoma 180 Ascites Cells by Combinations of Inhibitors of Nucleic Acid Biosynthesis and the Cupric Chelate of Kethoxal Bis- (thiosemicarbazone)l

The tumor-inhibitory jxitency of combinations of the cupric chelate of kethoxal bis(thiosemicarbazone) [Cu(II)KTS] with several compounds that cause inhibition of the synthesis of DNA by different biochemical mechanisms was assessed in Sarcoma 180 ascites cells. Cu(II)KTS prolonged the survival time of tumor-bearing mice, whereas neither cupric chloride, copper stéarate,nor kethoxal bis(thiose...

متن کامل

Inhibition of ascites cell growth by combinations of 6-thioguanine and azaserine.

Azaserine has been shown to be a potent in hibitor of de novo purine synthesis in both solid tumors (1, 13) and ascites cells (5, 6, 10). The duration of inhibition has been correlated with increases in the survival time of tumor-bearing hosts (7, 8). During inhibition of de novo purine synthesis by azaserine, the ascites cells maintain the ability to utilize preformed purines and pre sumably s...

متن کامل

The antitumor activity of Cu(II)KTS, the copper (II) chelate of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).

The antitumor activity of the copper(H) chelate of 3-ethoxy-2oxobutyraldehyde bis(thiosemicarbazone), Cu(II)KTS, against the Walker 256 carcinosarcoma in rats is shown, and the im portance of considering this chelate as the active intermediate in the mechanism of action of the free ligand, KTS, is indicated. The potentiation of the antitumor activity and toxicity of Cu(II)KTS by KTS and Vu(II) ...

متن کامل

Prevention of therapeutically induced regression of sarcoma 180 by immunologic enhancement.

The increased incidence of regression of Sarcoma 180 observed in Swiss tlaICt~ mice fed vitamin B(vdeficient diet or treated with 6-mercaplopurine or kethoxal-bis (thiosemicarbazone) was greatly reduced by active imnmnization of the host with frozen-thawed Sarcoma 180 homogenate or by passive transfer of specific hyperimmune serum. Similar results were obtained in C57BL/6 mice implanted with a ...

متن کامل

A model system for detecting drug impairment of antitumor host defenses.

A model system was developed taking advantage of the fact that the complete regression of Sarcoma 180 in vitamin Be-deficient Swiss mice is due to the immunological response of the host directed against the tumor. By comparing the effects of drug treatments given before or after tumor implantation, it was possible to dissociate the antitumor from the antihost effects of the drugs tested. The mo...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Cancer research

دوره 27 9  شماره 

صفحات  -

تاریخ انتشار 1967